Cargando…
Development of a PTHrP Chemiluminescent Immunoassay to Assess Humoral Hypercalcemia of Malignancy
Background: Measurement of parathyroid hormone related peptide (PTHrP) is helpful in the diagnosis and clinical management of patients suspected of humoral hypercalcemia of malignancy (HHM). In these patients uncontrolled release of PTHrP by tumor cells is responsible for the hypercalcemia and PTH c...
Autores principales: | Ashrafzadeh-Kian, Susan Louise, Bornhorst, Joshua, Algeciras-Schimnich, Alicia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089345/ http://dx.doi.org/10.1210/jendso/bvab048.2076 |
Ejemplares similares
-
SAT-153 PTHrP Mediated Hypercalcemia
por: Arguello, Mingxue
Publicado: (2020) -
Effects of Glucocorticoids and Calcitonin on Parathyroid Hormone‐related Protein (PTHrP) Gene Expression and PTHrP Release in Human Cancer Cells Causing Humoral Hypercalcemia
por: Kasono, Keizo, et al.
Publicado: (1991) -
SAT-LB63 A Case of PTHrP-Negative Hypercalcemia of Malignancy
por: Murati, Jonila, et al.
Publicado: (2020) -
1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma
por: Rodríguez-Gutiérrez, René, et al.
Publicado: (2014) -
PTHrP and breast cancer: more than hypercalcemia and bone metastases
por: Boras-Granic, Kata, et al.
Publicado: (2012)